Genflow Biosciences plc (GENF.L)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Eric Jean Leire M.D., MBA | Founder, CEO & Executive Director | 232.01k | -- | 1958 |
| Dr. Cedric Szpirer | Head of CMC | -- | -- | -- |
Genflow Biosciences plc
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Corporate Governance
Upcoming Events
May 1, 2025 at 10:59 AM UTC
Genflow Biosciences plc Earnings Date
Recent Events
Recent Events Information Not Available